Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Services-Health Services

Altaris to acquire Sharecare, Inc.

Announced Jun 21, 2024 · Closed Oct 31, 2024

Deal value$518MEV $419M
Premium85.0%To unaffected price
EV / Adj. EBITDA—1.0x EV / Revenue
ConsiderationAll cash$1.43 per share

Transaction

Acquirer
Altaris
Target
Sharecare, Inc. (SHCR)
Buyer type
Strategic
Offer price per share
$1.43
Enterprise value
$419M
Status
Closed Oct 31, 2024

Deal protections

Break fee (target pays)
$17.7M · 3.4%
Reverse fee (buyer pays)
—
Go-shop
No-shop
Financing
No financing condition

Advisors

To the acquirer
Not disclosed
To the target
Houlihan Lokey, MTS Health Partners

Sector context · Healthcare

Comparable deals
109 in the prior 24 months
Premium
85.0% vs. 58.0% sector median
EV / Adj. EBITDA
Sector median 17.1x
Break fee
3.4% vs. 3.5% sector median

Timeline

  1. AnnouncedJun 21, 2024
  2. Proxy filedAug 5, 2024
  3. Definitive proxySep 17, 2024
  4. Shareholder voteOct 17, 2024
  5. ClosedOct 22, 2024

Valuation · fairness opinions

Trading comparablesHoulihan Lokey$1.04$1.82
Trading comparablesHoulihan Lokey$0.97$1.65
Trading comparablesHoulihan Lokey$0.64$0.88
Trading comparablesHoulihan Lokey$1.08$1.60
Discounted cash flowHoulihan Lokey$1.16$1.75
Trading comparablesMTS Health Partners$0.75$1.10
Trading comparablesMTS Health Partners$1.45$2.15
Discounted cash flowMTS Health Partners$1.15$1.75
Discounted cash flowMTS Health Partners$0.75$1.00
Offer $1.43

Implied value per Sharecare, Inc. share by analysis, from Houlihan Lokey and MTS Health Partners · DCF discount rate 11.5%–12.5%.

Sources
  • 8-K (EX-99) · Jun 21, 2024
  • 8-K · Jun 21, 2024
  • 8-K (EX-99.1) · Oct 22, 2024
  • 8-K/A (EX-99.1) · Oct 31, 2024

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.